EW Edwards Lifesciences margins

Relative Growth: Rel. Growth: 46

Relative Strength: Rel. Strength: 50

Relative Valuation: Rel. Valuation: 17

Relative Profitability: Rel. Profitability: 67

Gross margin

77.8%

Operating margin

18%

EBITDA margin

25.4%

Net margin

15.4%

At present, Edwards Lifesciences reports a gross margin of 77.8%, an operating margin of 18%, an EBITDA margin of 25.4%, and a net margin of 15.4%. All reported margins declined year over year, led by net margin with a decline of 57.6 percentage points.

EW margin history

Gross, operating, EBITDA and net margin trends

Edwards Lifesciences's margins averaged 79.03% gross, 23.39% operating, 49.06% EBITDA, and 41.92% net during the last 3 years. All four current margins are lower than their three-year averages.

EW margin expansion

Year-over-year margin changes in percentage points

Net margin led the decline, falling by 57.6 percentage points, while the other available margins also decreased.

Gross margin expansion

-1.1pp

Operating margin expansion

-7pp

EBITDA margin expansion

-54.9pp

Net margin expansion

-57.6pp

EW Gross margin

Across the last 3 years, Edwards Lifesciences had an average gross margin of 79.03%. Against its three-year average, Edwards Lifesciences's gross margin is currently 77.8%, 1.2 percentage points below its three-year average. Looking back over the last 3 years, Edwards Lifesciences's gross margin reached 80.5% at its highest point in Dec 2023 and 77.8% at its lowest in Jun 2026.

EW Operating margin

Over the last 3 years, Edwards Lifesciences's operating margin averaged 23.39%. The current operating margin of 18% is 5.4 percentage points below its three-year average. During this period, operating margin reached a high of 27.4% in Jun 2024 and a low of 16.9% in Mar 2026.

EW EBITDA margin

The average EBITDA margin for Edwards Lifesciences was 49.06% in the last 3 years. As of the latest period, the current EBITDA margin for Edwards Lifesciences is 25.4%, 23.7 percentage points below its three-year average. The EBITDA margin for Edwards Lifesciences moved between 24.3% in Mar 2026 and 84.5% in Sep 2024.

EW Net margin

Edwards Lifesciences recorded an average net margin of 41.92% across the last 3 years. Edwards Lifesciences currently reports a net margin of 15.4%, 26.5 percentage points below its three-year average. The highest net margin for Edwards Lifesciences was 78.2% in Sep 2024, while the lowest was 15.4% in Jun 2026.

EW margin group comparison

Margins compared with peer-group, industry and sector averages

With a gross margin of 77.8%, EW stands higher than the Healthcare sector, the industry and its peers average. Looking at the Healthcare sector average of 68.4%, Edwards Lifesciences's gross margin is 14% higher.

EW margin peer comparison

Compare margins with selected peers

Frequently asked questions

What is Edwards Lifesciences's gross margin?

As of Jun 30, 2026, EW has a gross margin of 77.8%.

What is Edwards Lifesciences's operating margin?

The current operating margin for EW is 18% as of Jun 30, 2026.

What is Edwards Lifesciences's EBITDA margin?

For the period ending Jun 30, 2026, EW recorded an EBITDA margin of 25.4%.

What is Edwards Lifesciences's net margin?

As of Jun 30, 2026, EW has a net margin of 15.4%.

What are the average margins of EW?

Edwards Lifesciences's average margins over the last 3 years were 79.0% gross, 23.4% operating, 49.1% EBITDA, and 41.9% net.

What are the highest historical margins of EW?

Edwards Lifesciences's highest recorded margins during the past 5 years were 83.8% gross in Dec 2022, 32.8% operating in Dec 2022, 84.5% EBITDA in Sep 2024, and 78.2% net in Sep 2024.

What are the lowest historical margins of EW?

Looking back across 5 years, EW reached its lowest margins at 76.1% gross in Dec 2021, 16.9% operating in Mar 2026, 24.3% EBITDA in Mar 2026, and 15.4% net in Jun 2026.